(Q40059658)

English

Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia

scientific article published on November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Matsunaga T

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Fukai F

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Miura S

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Nakane Y

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Owaki T

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Kodama H

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Tanaka M

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Nagaya T

8

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Takimoto R

9

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Takayama T

10

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Niitsu Y

11

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

publication date

1 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

353-360

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Fibronectin harbors anticell adhesive activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Induction of programmed cell death in human hematopoietic cell lines by fibronectin via its interaction with very late antigen 5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Requirement for VLA-4 and VLA-5 integrins in lymphoma cells binding to and migration beneath stromal cells in culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Identification of putative ligand-binding sites of the integrin alpha 4 beta 1 (VLA-4, CD49d/CD29)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Ex vivo expansion of human umbilical cord hematopoietic progenitor cells using a coculture system with human telomerase catalytic subunit (hTERT)-transfected human stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Comparing the importance of prognostic factors in Cox and logistic regression using SAS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

T cell receptor- and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Isolation of murine pluripotent hemopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Cell adhesion-mediated drug resistance (CAM-DR) protects the K562 chronic myelogenous leukemia cell line from apoptosis induced by BCR/ABL inhibition, cytotoxic drugs, and gamma-irradiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Strategies to improve plasma half life time of peptide and protein drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Stability of protein pharmaceuticals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

PEGylation, successful approach to drug delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

21 January 2018

Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

7 January 2021

based on heuristic

inferred from DOI database lookup

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibronectin peptides derived from two distinct regions stimulate adipocyte differentiation by preventing fibronectin matrix assembly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

7 January 2021

based on heuristic

inferred from DOI database lookup

VLA proteins in the integrin family: structures, functions, and their role on leukocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

7 January 2021

based on heuristic

inferred from DOI database lookup

Critical amino acid residues for ligand binding are clustered in a predicted beta-turn of the third N-terminal repeat in the integrin alpha 4 and alpha 5 subunits.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405017

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2405017

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40059658&oldid=2203354722"